BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8381218)

  • 1. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein.
    Caruso M; Martelli F; Giordano A; Felsani A
    Oncogene; 1993 Feb; 8(2):267-78. PubMed ID: 8381218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of c-fos promoter by MyoD on muscle cell differentiation.
    Trouche D; Grigoriev M; Lenormand JL; Robin P; Leibovitch SA; Sassone-Corsi P; Harel-Bellan A
    Nature; 1993 May; 363(6424):79-82. PubMed ID: 8386804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
    Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
    Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters.
    Webster KA; Muscat GE; Kedes L
    Nature; 1988 Apr; 332(6164):553-7. PubMed ID: 2965790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus 5 E1A represses muscle-specific enhancers and inhibits expression of the myogenic regulatory factor genes, MyoD1 and myogenin.
    Enkemann SA; Konieczny SF; Taparowsky EJ
    Cell Growth Differ; 1990 Aug; 1(8):375-82. PubMed ID: 2177635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription-repression domain of the adenovirus E1A oncoprotein targets p300 at the promoter.
    Green M; Panesar NK; Loewenstein PM
    Oncogene; 2008 Jul; 27(32):4446-55. PubMed ID: 18408753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation.
    Postigo AA; Dean DC
    EMBO J; 1997 Jul; 16(13):3935-43. PubMed ID: 9233803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
    Grasberger H; Ye H; Mashima H; Bell GI
    Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
    Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
    Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early stages of myogenesis as seen through the action of the myf-5 gene].
    Buckingham M
    C R Seances Soc Biol Fil; 1997; 191(1):43-54. PubMed ID: 9181127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
    Tedesco D; Vesco C
    Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of in vitro myogenic differentiation by a polyomavirus early function.
    Maione R; Fimia GM; Amati P
    Oncogene; 1992 Jan; 7(1):85-93. PubMed ID: 1311065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of c-Jun-induced mouse major histocompatibility class I promoter (H-2Kb) activity by the Adenovirus type 12-unique 52R E1A protein.
    Brockmann D; Schäfer D; Kirch HC; Esche H
    Oncogene; 1996 Apr; 12(8):1715-25. PubMed ID: 8622892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5.
    Braun T; Bober E; Arnold HH
    Genes Dev; 1992 May; 6(5):888-902. PubMed ID: 1315706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products.
    Moran E
    Nature; 1988 Jul; 334(6178):168-70. PubMed ID: 2968523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products.
    Hagmeyer BM; Angel P; van Dam H
    Bioessays; 1995 Jul; 17(7):621-9. PubMed ID: 7646484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.
    Sandmöller A; Meents H; Arnold HH
    Mol Cell Biol; 1996 Oct; 16(10):5846-56. PubMed ID: 8816499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus 5 E1A proteins disrupt the neuronal phenotype and growth factor responsiveness of PC12 cells by a conserved region 1-dependent mechanism.
    Boulukos KE; Ziff EB
    Oncogene; 1993 Feb; 8(2):237-48. PubMed ID: 8093977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.